投稿信息
投稿信息
审稿周期
投稿命中率
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%)
自引率
4.9 %
年文章数
1635
作者需知
暂无数据
NCBI查询
期刊简介
稿件收录要求
稿件收录要求
Published by Adis International Limited (now part of Wolters Kluwer Health).
ISSN: 1170-229X.
Drugs & Aging provides you with important and current information on drug use in the aging population as well as diseases of the aging and the effects of aging on drug treatment. By providing peer reviewed, impartial and reliable data, the review articles in Drugs & Aging assist you in making clinical decisions and treatment choices based on international consensus, keeping you well informed on important issues, up to date with emerging treatments, and aware of the place of specific drugs in therapy. The Journal aims to promote optimum drug therapy in older adults by providing a regular programme of review articles covering the most important aspects of clinical pharmacology and patient management in this unique group. Physiological changes during aging which have implications for drug therapy also fall within the scope of the Journal.
Drugs & Aging provides you with important and current information on drug use in the aging population as well as diseases of the aging and the effects of aging on drug treatment. By providing peer reviewed, impartial and reliable data, the review articles in Drugs & Aging assist you in making clinical decisions and treatment choices based on international consensus, keeping you well informed on important issues, up to date with emerging treatments, and aware of the place of specific drugs in therapy. The Journal aims to promote optimum drug therapy in older adults by providing a regular programme of review articles covering the most important aspects of clinical pharmacology and patient management in this unique group. Physiological changes during aging which have implications for drug therapy also fall within the scope of the Journal.
